(CIDRAP News) – Coverage rates for vaccines recommended for adults remain stubbornly low, except for modest gains in two, the diphtheria with acellular pertussis vaccine (Tdap) and the human papillomavirus (HPV) vaccine in women, according to new federal estimates today.
(CIDRAP News) In an effort to protect males against certain cancers and to indirectly protect women, the federal government's vaccine advisory group today approved a recommendation for routine vaccination of boys ages 11 or 12 with the human papillomavirus (HPV) vaccine.
(CIDRAP News) An annual survey found that increases in human papillomavirus vaccine (HPV) vaccination in US adolescents are lagging those of two other vaccines—the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine and the meningococcal conjugate vaccine (MenACWY)—the Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) An Institute of Medicine (IOM) analysis found few health problems that were clearly linked to eight common vaccines, according to a report released today.
Amheim-Dahlstrom L, Pasternak B, Svanstrom H, et al. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ 2013 Oct 9;347:159906
Bernard E, Pons-Salort M, Favre M, et al. Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies. BMC Infect Dis 2013 Aug 13;13:373
Blomberg M, Dehlendorff C, Munk C, et al. Strongly decreased risk of genital warts after vaccination against HPV: nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clin Infect Dis 2013 (published online Jun 26)
Campbell CMP, Lin HY, Fulp W, et al. Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. J Infect Dis 2013 Aug 1;208(3):373-84
Drolet M, Boily MC, Van de Velde N, et al. Vaccinating girls and boys with different human papillomavirus vaccines: can it optimize population-level effectiveness? PLoS One 2013 Jun 26;8(6):e67072
Flagg EW, Schweartz R, Weinstock H. Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination. Am J Public Health 2013 Aug;103(8):1428-35
Forslund O, Johansson H, Madsen KG, et al. The nasal mucosa contains a large diversity of human papillomavirus from the Beta- and Gammapapillomavirus genera. J Infect Dis 2013 (published online Jul 21)
Goldstone SE, Jessen H, Palefsky JM, et al. Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine 2013 Aug 20;31(3):3849-55
Heiligenberg M, Alberts CJ, Waterboer T, et al. Route of sexual exposure is independently associated with seropositivity to HPV-16 and HPV-18 among clients of an STI clinic in the Netherlands. J Infect Dis 2013 (published online Jul 15)
Kreimer AR, Campbell CMP, Lin HY, et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet 2013 (published online Jul 2)
Lang Kuhs KA, Gonzalez P, Struijk L, et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J Infect Dis2013 (published online Sep 6)
Lee SM, Park JS, Norwitz ER, et al. Risk of vertical transmission of human papillomavirus throughout pregnancy: a prospective study. PLoS One 2013 Jun 13:8(6):e66368
Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 2013 Aug 1;208(3):385-93
Mcdonnold M, Dunn H, Hester A, et al. High risk human papillomavirus at entry to prenatal care and risk of preeclampsia. Am J Obstet Gynecol 2013 (published online Oct 2)
Moss JL, Gilkey MB, Griffith T, et al. Organizational correlates of adolescent immunization: findings of a state-wide study of primary care clinics in North Carolina. Vaccine 2013 Sep;31(40):4436-41
Nelson EA, Lam HS, Choi KC, et al. A pilot randomized study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18-26 years. Vaccine 2013 Jul 25;31(34):3452-60
Newman PA, Logie CH, Doukas N, et al. HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect 2013 (published online Jul 4)
Osazuwa-Peters N.Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—do we need a broader vaccine policy? Vaccine 2013 (published online Oct 3)
Potts A, Sinka K, Love J, et al. High uptake of HPV immunisation in Scotland—perspectives on maximizing uptake. Euro Surveill 2013 Sep 26;18(39):pii=20593
Ratanasiripong NT, Chai KT. A concept analysis of attitude toward getting vaccinated against human papillomavirus. Nurs Res Pract 2013 May 28;2013:373805
Wigle J, Coast E, Watson-Jones D. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects. Vaccine 2013 Aug 20;31(37):3811-7
